Concepedia

Robert Goldman

RG

Statistics

Publications

64

Citations

6.5K

H-Index

37

Active since

1973

Affiliations

Vion Pharmaceuticals (United States)(Current)

University of Michigan

Sunovion (United States)

Zucker Hillside Hospital

Northwell Health

Robert Goldman is an author at Vion Pharmaceuticals (United States) specializing in medicine, psychiatry, and psychopharmacology.

Publications per year

1973–2022

64

Publications

64

Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder

Delbert G. Robinson, Margaret G. Woerner, Jose Ma. J. Alvir et al. · Archives of General Psychiatry · 1999 · 1.3K citations

, , +17

Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder

Robert M. Bilder, Robert Goldman, Jan Volavka et al. · American Journal of Psychiatry · 2002 · 538 citations

, , +17

Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder

Delbert G. Robinson, Margaret G. Woerner, Jose Ma. J. Alvir et al. · American Journal of Psychiatry · 1999 · 466 citations

, , +17

Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia

Terry E. Goldberg, Robert Goldman, Katherine E. Burdick et al. · Archives of General Psychiatry · 2007 · 396 citations

, , +17

Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia

Robert M. Bilder, Jan Volavka, Pál Czobor et al. · Biological Psychiatry · 2002 · 325 citations

, , +16

1–5 of 64